Pranlukast attenuates hydrogen peroxide-induced necrosis in endothelial cells by inhibiting oxygen reactive species-mediated collapse of mitochondrial membrane potential

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 4, 2011, Pages 479-488

  Zhao, Rui ^a,b   Fang, San Hua ^a   Lin, Ka Na ^a   Huang, Xue Qin ^a   Lu, Yun Bi ^a   Zhang, Wei Ping ^a   Wei, Er Qing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

endothelial cell; hydrogen peroxide; mitochondrial membrane potential; Pranlukast; reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; CATALASE; CYCLOSPORIN A; DICHLORODIHYDROFLUORESCEIN; DICHLORODIHYDROFLUORESCEIN DIACETATE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PRANLUKAST; SUPEROXIDE DISMUTASE; ZILEUTON;

APOPTOSIS; ARTICLE; ATTENUATION; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME;

CELL LINE; CELL SURVIVAL; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; LEUKOTRIENE ANTAGONISTS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NECROSIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 79954992059     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821076d3     Document Type: Article

References (43)

1. Panettieri RA, Tan EM, Ciocca V, et al. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am JRespir Cell Mol Biol. 1998;19:453-461. (Pubitemid 128354215)
2. O'Shaughnessy TC, GeorgiouP, Howland K, et al. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. Thorax. 1997;52:519-522. (Pubitemid 27298502)
3. Fukushima C, Matsuse H, Hishikawa Y, et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol. 2005;136:165-172. (Pubitemid 40463242)
4. Tomari S, Matsuse H, Machida I, et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy. 2003;33:795-801. (Pubitemid 36760512)
5. IchiyamaT, Hasegawa S, Umeda M, et al. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells. Clin Exp Allergy. 2003;33:802-807. (Pubitemid 36760513)
6. Ishinaga H, Takeuchi K, Kishioka C, et al. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells. Pharmacology. 2005;73:89-96. (Pubitemid 40082319)
7. Fang SH, Yuan YM, Peng F, et al. Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species produc-tion andnuclear factor-kappab activation. J CardiovascPharmacol. 2009; 53:77-85.
8. Gille JJ, Joenje H. Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res. 1992;275:405-414.
9. Yung LM, Leung FP, Yao X, et al. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006;6:1-19. (Pubitemid 43803123)
10. Liu HT, Li WM, Xu G, et al. Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells. Pharmacol Res. 2009;59:167-175.
11. Wang W, Sun F, An Y et al. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur J Pharmacol. 2009;613:19-23.
12. Zhang R, Chae S, Kang KA, et al. Protective effect of butin against hydrogen peroxide-induced apoptosis by scavenging reactive oxygen species and activating antioxidant enzymes. Mol Cell Biochem. 2008;318:33-42.
13. Yu HH, Hur JM, Seo SJ, et al. Protective effect of ursolic acid from Cornus officinalis on the hydrogen peroxide-induced damage ofHEI-OC1 auditory cells. Am J Chin Med. 2009;37:735-746.
14. Palomba L, Sestili P, Columbaro M, et al. Apoptosis and necrosis following exposure of U937 cells to increasing concentrations of hydrogen peroxide: the effect of the poly(ADP-ribose)polymerase inhibitor 3-aminobenzamide. Biochem Pharmacol. 1999;58:1743-1750. (Pubitemid 29505414)
15. Troyano A, Sancho P, Fernandez C, et al. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells. Cell Death Differ. 2003; 10:889-898. (Pubitemid 36939699)
16. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 2003;304:463-470. (Pubitemid 36506518)
17. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 2000;141:2003-2010. (Pubitemid 32274349)
18. Gong G, Qin Y Huang W, et al. Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mito-chondrial dysfunction pathway in human umbilical vein endothelial cells. Eur J Pharmacol. 2010;628:27-35.
19. Hamahata K, Adachi S, Matsubara H, et al. Mitochondrial dysfunction is related to necrosis-like programmed cell death induced by A23187 in CEM cells. Eur J Pharmacol. 2005;516:187-196. (Pubitemid 40922737)
20. Zhuang S, Kinsey GR, Yan Y et al. Extracellular signal-regulated kinase activation mediates mitochondrial dysfunction and necrosis induced by hydrogen peroxide in renal proximal tubular cells. J Pharmacol Exp Ther. 2008;325:732-740. (Pubitemid 351724319)
21. Zamzami N, Larochette N, Kroemer G Mitochondrial permeability transition in apoptosis andnecrosis. Cell Death Differ. 2005;12(suppl 2): 1478-1480. (Pubitemid 41553982)
22. Oka N, Wang L, Mi W, et al. Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest. J Thorac Cardiovasc Surg. 2008;135:123-130, 130 e1-e2.
23. Qian T, Nieminen AL, Herman B, et al. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol. 1997;273(pt 1):C1783-C1792.
24. Ahn K, Pan S, Beningo K, et al. A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells. Life Sci. 1995;56:2331-2341.
25. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 1983;80:3734-3737. (Pubitemid 13063134)
26. Bouis D, Hospers GA, Meijer C, et al. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis. 2001;4:91-102. (Pubitemid 34032695)
27. Cook-Moreau JM, El-Makhour Hojeij Y, Barriere G, et al. Expression of 5-lipoxygenase (5-LOX) in T lymphocytes. Immunology. 2007;122: 157-166. (Pubitemid 47389944)
28. Zhang WP, Wei EQ, Mei RH, et al. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin. 2002;23:871-877.
29. Ishizaka A, Hasegawa N, Sakamaki F, et al. Effects of ONO-1078, a peptide leukotriene antagonist, on endotoxin-induced acute lung injury. Am JRespir Crit Care Med. 1994;150(pt 1):1325-1331.
30. Varani J, Ward PA. Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals. 1994;3:1-14. (Pubitemid 24196238)
31. Kahles T, Luedike P, Endres M, et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke. 2007;38: 3000-3006. (Pubitemid 350035696)
32. Ji BS, Gao Y Protective effect oftrihexyphenidyl on hydrogen peroxide-induced oxidative damage in PC12 cells. NeurosciLett. 2008;437:50-54.
33. Ji LL, Gomez-Cabrera MC, Vina J. Exercise and hormesis: activation of cellular antioxidant signaling pathway Ann N Y Acad Sci. 2006;1067: 425-435. (Pubitemid 43806355)
34. Marczin N, El-Habashi N, Hoare GS, et al. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys. 2003;420:222-236. (Pubitemid 37491106)
35. Seo DW, Lopez-Meraz ML, Allen S, et al. Contribution ofamitochondrial pathway to excitotoxic neuronal necrosis. J Neurosci Res. 2009;87: 2087-2094.
36. Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 2009;14:469-477.
37. Svoboda N, Kerschbaum HH. l-Glutamine-induced apoptosis in microglia is mediated by mitochondrial dysfunction. Eur J Neurosci. 2009;30: 196-206.
38. Guidarelli A, Cerioni L, Tommasini I, et al. Role of Bcl-2 in the arachidonate-mediated survival signaling preventing mitochondrial permeability transition-dependent U937 cell necrosis induced by peroxynitrite. Free Radic Biol Med. 2005;39:1638-1649. (Pubitemid 41642595)
39. Kon K, Kim JS, Jaeschke H, et al. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology. 2004;40:1170-1179. (Pubitemid 39425573)
40. Chau LY, Hoover RL, Austen KF, et al. Subcellular distribution of leukotriene C4 binding units in cultured bovine aortic endothelial cells. J Immunol. 1986;137:1985-1992. (Pubitemid 16021115)
41. Zhang YY, Walker JL, Huang A, et al. Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem J. 2002;361(pt 2):267-276. (Pubitemid 34174493)
42. Feinmark SJ. The role of the endothelial cell in leukotriene biosynthesis. Am Rev Respir Dis. 1992;146(pt 2):S51-S55.
43. Claesson HE, Haeggstrom J. Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4. Eur JBiochem. 1988;173:93-100.